ALPHACENTRIC ADVISORS LLC CytomX Therapeutics, Inc. Transaction History

ALPHACENTRIC ADVISORS LLC portfolio value:

$373,000
portfolio value

CytomX Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 257.5K shares 373K $1.45 257.5K